跳至主要内容
临床试验/NCT01919151
NCT01919151Unknown不适用

The Process of Metastasis in Colorectal Cancer Tumour Biology and Prognostic Factors in Pancreatic Cancer

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2008年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
Survival

研究概览

简要总结

Prognostic and predictive value of assessing the patients micrometastasis status in blood and bone marrow when diagnosed GI cancer. 2 different patient subgroups are currently studied, patients with cancer of the pancreas and patients with liver metastasis secondary to colorectal cancer.

Our hypothesis is that patients with detective circulating tumor cells in the blood or disseminated tumour cells in their bone marrow at diagnosis have a more advanced disease than negative patients. This information may be of therapeutic interest.

详细描述

Oncological and overall outcome of the included patients are consecutively registrated at the out-patient clinic. At end of follow-up these survival data are analysed according to the presence of tumor cells in blood and bone marrow, and the prognostic impact of their presence are assessed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Histological proven adenocarcinoma of the pancreas
  • Histological/radiological verified colorectal liver metastases
  • Consent capable patient
  • Signed written, informed consent

排除标准

  • Patient'history of other malignancy

结局指标

主要结局

Survival

时间窗: 5 year

次要结局

未报告次要终点

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验